CareDx, Inc.

As of September 30, 2026, CareDx, Inc. carries a market capitalization of 3.41B, placing it among publicly traded companies globally. Its enterprise value stands at 3.19B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CareDx, Inc.'s next confirmed earnings release is scheduled for March 3, 2027.

As of September 30, 2026, CareDx, Inc. has 52.46M shares outstanding.

As of September 30, 2026, CareDx, Inc. trades at a trailing price-to-earnings ratio of 26.01. The price-to-sales ratio is 6.73, and the price-to-book ratio stands at 7.29.

As of September 30, 2026, CareDx, Inc. trades at an EV/EBITDA multiple of 22.74 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 6.41 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 27.37 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.19B versus a market cap of 3.41B, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2026, CareDx, Inc. maintains a current ratio of 2.31, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended September 30, 2026, CareDx, Inc. posted a return on equity (ROE) of 33.04, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 23.96, measuring how efficiently the asset base is converted into earnings. The company generates approximately 650,190.85 in revenue per employee across its workforce of 765.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.71 indicates how many times CareDx, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2026, CareDx, Inc. recorded an income tax benefit of -4.40M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 124.22M, leaving 128.63M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on November 10, 2026, CareDx, Inc.'s stock has gained approximately 383.65% over the past 52 weeks. The 50-day moving average sits at 64.53, while the 200-day moving average is 35.82.

Over the twelve months ended September 30, 2026, CareDx, Inc. generated 497.40M in revenue and converted that into 128.63M in net income, yielding earnings per share of 2.42. EBITDA reached 140.18M, while operating income came in at 4.13M.

As of September 30, 2026, CareDx, Inc. holds 250.48M in cash and equivalents against 29.00M in total debt, resulting in a net debt position of -250.48M. Total book value stands at 467.46M, with working capital of 182.32M providing operational flexibility.

CareDx, Inc. produced 69.02M in operating cash flow over the twelve months ended September 30, 2026. After subtracting -3.82M in capital expenditures, free cash flow totaled 65.20M - equivalent to 1.27 per share.

Over the twelve months ended September 30, 2026, CareDx, Inc. posted a gross margin of 70.97, reflecting its pricing power and cost economics. The operating margin of 0.83 and net profit margin of 25.86 provide insight into operational efficiency.

These figures cover the twelve months ended September 30, 2026. Free cash flow yield stands at 1.89, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 0.53, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to CareDx, Inc. shareholders.

As of September 30, 2026, CareDx, Inc. has an Altman Z-Score of 11.89, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.